Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Drug Discovery Today
|
July 19, 2023
Regulatory benefit-risk assessment of oncology drugs: A systematic review of FDA and EMA approvals
Cathy Anne Pinto, Zaneta Balantac, Shahrul Mt-Isa, et al.
Journal of Asthma and Allergy
|
October 31, 2022
Suboptimal Control of Asthma Among Diverse Patients: A US Mixed Methods Focus Group Study
Maureen George, Zaneta Balantac, Chris Gillette, et al.
The Patient
|
April 8, 2021
Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis
Tommi Tervonen, Pareen Vora, Jaein Seo, et al.
The Patient
|
February 2, 2025
Transferability of Preferences; for Better or ….?
Jorien Veldwijk, Semra Ozdemir, Michael Bui, et al.
British Journal of Clinical Pharmacology
|
March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis
Jonathan Mauer, Kristin Bullok, Stephen Watt, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
January 30, 2023
Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment
Tommi Tervonen, Robert J Fox, Anne Brooks, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2023
Current Health State Affected Patient Preferences More Than Disease Status: A Discrete Choice Experiment in Multiple Myeloma
Tommi Tervonen, Ashley Duenas, Hannah Collacott, et al.
The Patient
|
March 9, 2021
Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany
Jianming He, Ashley Duenas, Hannah Collacott, et al.
Pharmacoepidemiology and Drug Safety
|
March 9, 2019
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy
Cathy Anne Pinto, Tommi Tervonen, Kevin Marsh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 23, 2022
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial
Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Drug Discovery Today
|
July 19, 2023
Regulatory benefit-risk assessment of oncology drugs: A systematic review of FDA and EMA approvals
Cathy Anne Pinto, Zaneta Balantac, Shahrul Mt-Isa, et al.
Journal of Asthma and Allergy
|
October 31, 2022
Suboptimal Control of Asthma Among Diverse Patients: A US Mixed Methods Focus Group Study
Maureen George, Zaneta Balantac, Chris Gillette, et al.
The Patient
|
April 8, 2021
Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis
Tommi Tervonen, Pareen Vora, Jaein Seo, et al.
The Patient
|
February 2, 2025
Transferability of Preferences; for Better or ….?
Jorien Veldwijk, Semra Ozdemir, Michael Bui, et al.
British Journal of Clinical Pharmacology
|
March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis
Jonathan Mauer, Kristin Bullok, Stephen Watt, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
January 30, 2023
Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment
Tommi Tervonen, Robert J Fox, Anne Brooks, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2023
Current Health State Affected Patient Preferences More Than Disease Status: A Discrete Choice Experiment in Multiple Myeloma
Tommi Tervonen, Ashley Duenas, Hannah Collacott, et al.
The Patient
|
March 9, 2021
Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany
Jianming He, Ashley Duenas, Hannah Collacott, et al.
Pharmacoepidemiology and Drug Safety
|
March 9, 2019
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy
Cathy Anne Pinto, Tommi Tervonen, Kevin Marsh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 23, 2022
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial
Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer, et al.
Page
of 6